Cargando…
Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes
BACKGROUND: Neuroblastoma patients show heterogeneous clinical courses ranging from life-threatening progression to spontaneous regression. Recently, gene expression profiles of neuroblastoma tumours were associated with clinically different phenotypes. However, such data is still rare for important...
Autores principales: | Warnat, Patrick, Oberthuer, André, Fischer, Matthias, Westermann, Frank, Eils, Roland, Brors, Benedikt |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904223/ https://www.ncbi.nlm.nih.gov/pubmed/17531100 http://dx.doi.org/10.1186/1471-2407-7-89 |
Ejemplares similares
-
Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes
por: Warnat, Patrick, et al.
Publicado: (2005) -
Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients
por: Oberthuer, A, et al.
Publicado: (2010) -
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
por: Westermann, Frank, et al.
Publicado: (2008) -
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
por: Rosswog, Carolina, et al.
Publicado: (2017) -
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma
por: Lau, Diana T., et al.
Publicado: (2015)